Back

Maestro, I.; Boya, P.; Martinez, A.  [2020]. Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases. Expert Opin Ther Targets 2020, 24 (3), 231-243.

Peřinová, R.; Maafi, N.; Korábečný, J.; Kohelová, E.; De Simone, A.; Al Mamun, A.; Hulcová, D.; Marková, J.; Kučera, T.; Jun, D.; Šafratová, M.; Maříková, J.; Andrisano, V.; Jenčo, J.; Kuneš, J.; Martinez, A.; Nováková, L.; Cahlíková, L.  [2020]. Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer's disease. Bioorg Chem 2020, 100, 103928.

Di Martino, R. M. C.; Pruccoli, L.; Bisi, A.; Gobbi, S.; Rampa, A.; Martinez, A.; Pérez, C.; Martinez-Gonzalez, L.; Paglione, M.; Di Schiavi, E.; Seghetti, F.; Tarozzi, A.; Belluti, F.  [2020]. Novel curcumin-diethyl fumarate hybrid as a dualistic GSK-3β inhibitor/Nrf2 inducer for the treatment of Parkinson's disease. ACS Chem Neurosci 2020, 11 (17), 2728-2740.

Martinez-Gonzalez, L.; Rodríguez-Cueto, C.; Cabezudo, D.; Bartolome, F.; Andrés-Benito, P.; Ferrer, I.; Gil, C.; Martin-Requero, A.; Fernández-Ruiz, J.; Martinez, A.; de Lago, E.  [2020]. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment. Sci. Rep. 2020, 10, 4449

Sebastián-Pérez, V.; García-Rubia, A.; Seif el-Din, S. H.; Sabra, A.-N. A.; El-Lakkany, N. M.; William, S.; Blundell, T. L.; Maes, L.; Martinez, A.; Campillo, N. E.; Botros, S. S.; Gil, C.  [2020]. Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools. J. Enz. Inh. Med. Chem. 2020, 35, 511-523.

Martínez de Iturrate, P.; Sebastián-Pérez, V.; Nácher-Vázquez, M.; Tremper, C. S.; Smirlis, D.; Martin, J.; Martínez, A.; Campillo, N. E.; Rivas, L.; Gil, C.  [2020]. Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3. J. Enz. Inh. Med. Chem. 2020,35, 199-210.

Canal-Martín, A.; Sastre, J.; Sánchez-Barrena, M. J.; Canales, A.; Baldominos, S.; Pascual, N.; Martínez-González, L.; Molero, D.; Fernández-Valle, M. E.; Sáez, E.; Blanco-Gabella, P.; Gómez-Rubio, E.; Martín-Santamaría, S.; Sáiz, A.; Mansilla, A.; Cañada, F. J.; Jiménez-Barbero, J.; Martínez, A.; Pérez-Fernández, R.  [2019]. Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library. Nat Commun 2019, 10, 2798.

Botros, S. S.; Williams, S.; Sabra, A-N. A.; El-Lakkany, N. M.; Seif el-Din, S. H.; Sterk, G. J.; Salado, I. G.; Augustyns, K.; García-Rubia, A.; Sebastian-Perez, V.; Maes, L.; Munday, J. C.; Leurs, R.; Gil, C.; De Koning, H. P  [2019]. Antischistosomal screening of a PDE-focused library identifies imidazoles with in vitro and in vivo activity. Int. J. Parasitol.: Drugs Drug Resist. 2019, 9, 35-43.

de Araújo, J. S.; Garcia-Rubia, A.; Sebastian-Perez, V.; Kalejaiye, T. D.; Bernardino da Silva, P.; Fonseca-Berzal, C. R.; Maes, L.; De Koning, H.; Soeiro, M. N. C.; Gil, C.  [2019]. Imidazole derivatives as promising agents for the treatment of Chagas disease. Antimicrob. Agents Chemother. 2019, 63, e02156-18.

Sebastián-Pérez, V.; Martinez, M. J.; Gil, C.; Campillo, N. E.; Martinez, A.; Ponzoni, I.  [2019]. Inference of QSAR Models for identifying LRRK2 inhibitors for the treatment of Parkinson’s Disease. J. Integr. Bioinform. 2019, 20180063.

Martinez, A.; Gil, C.  [2019]. “Protein kinase inhibitors for the treatment of Multiple Sclerosis” en Emerging Drugs and Targets for Multiple Sclerosis. Ed. A. Martínez, Royal Society of Chemistry. 2019, 170-196.

Sebastian-Pérez, V.; Schroeder, S.; Munday, J. C.; van der Meer, T.; Zaldívar-Díez, J.; Siderius, M.; de Koning, H. P.; Brown, D.; Martinez, A.; Campillo, N. E.; Leurs, R.; Gil, C.  [2019]. Discovery of novel Schistosoma mansoni SmPDE4A inhibitors as potential agents against schistosomiasis. Fut. Med. Chem. 2019, 11, 1703-1720.

Ponzoni, I.; Sebastian-Perez, V.; Martinez, M. J.; Roca, C.; De la Cruz, C.; Perez, C.; Cravero, F.; Vazquez, G.; Paez, J. A.; Diaz, M. F.; Campillo, N. E.  [2019]. QSAR classification models for predicting the activity of inhibitors of Beta-Secretase (BACE1) associated with Alzheimer's disease. Sci. Rep. 2019, 9, 9102.

Kraft, C.; Boya, P.; Codogno, P.; Elazar, Z.; Eskelinen, E. L.; Farres, J.; Kirkin, V.; Jungbluth, H.; Martinez, A.; Pless, O.; Primard, C.; Proikas-Cezanne, T.; Simonsen, A.; Reggiori, F.  [2018]. Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy. Autophagy 2018, 1-5.

Posa, D.; Martinez-Gonzalez, L.; Bartolome, F.; Nagaraj, S.; Porras, G.; Martinez, A.; Martin-Requero, A.  [2018]. Recapitulation of pathological TDP-43 features in immortalized lymphocytes from sporadic ALS patients. Mol. Neurobiol. 2018, doi: 10.1007/s12035-018-1249-8.

Decara, J.; Serrano, A.; Pavon, F. J.; Rivera, P.; Arco, R.; Gavito, A.; Vargas, A.; Navarro, J. A.; Tovar, R.; Lopez-Gambero, A. J.; Martinez, A.; Suarez, J.; Rodriguez de Fonseca, F.; Baixeras, E.  [2018]. The adiponectin promoter activator NP-1 induces high levels of circulating TNFalpha and weight loss in obese (fa/fa) Zucker rats. Sci. Rep. 2018, 8, 9858.

Cheng, Y.; Desse, S.; Martinez, A.; Worthen, R. J.; Jope, R. S.; Beurel, E.  [2018]. TNFalpha disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav. Immun. 2018, 69, 556-567.

Benek, O.; Hroch, L.; Aitken, L.; Gunn-Moore, F.; Vinklarova, L.; Kuca, K.; Perez, D. I.; Perez, C.; Martinez, A.; Fisar, Z.; Musilek, K.  [2018]. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders. J. Enzyme Inhib. Med. Chem. 2018, 33, 665-670.

Alten, B.; Yesiltepe, M.; Bayraktar, E.; Tas, S. T.; Gocmen, A. Y.; Kursungoz, C.; Martinez, A.; Sara, Y.  [2018]. High-fructose corn syrup consumption in adolescent rats causes bipolar-like behavioural phenotype with hyperexcitability in hippocampal CA3-CA1 synapses. Br. J. Pharmacol. 2018, 175, 4450-4463.

Sebastián-Pérez, V.; Hendrickx, S.; Munday, J. C.; Kalejaiye, T.; Martínez, A.; Campillo, N. E.; de Koning, H.; Caljon, G.; Maes, L.; Gil, C.  [2018]. Cyclic nucleotide specific phosphodiesterases as potential drug targets for anti-Leishmania therapy. Antimicrob. Agents Chemother. 2018, 62, e00603-18.